12:00 AM
 | 
Aug 20, 2007
 |  BioCentury  |  Finance

Making the numbers

Making the numbers

Making the numbersBy decreasing its share base through stock buybacks, Amgen has boosted its EPS...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >